[Translation] A randomized, double-blind, placebo-controlled, Phase Ib/IIa clinical study to evaluate the safety, tolerability, pharmacokinetics and efficacy of multiple ascending doses of SIPI6398 in patients with schizophrenia
主要目的:
1. 评价SIPI6398片在精神分裂症患者中多次给药的安全性。
次要目的:
1. 评价SIPI6398片在精神分裂症患者中多次给药的药代动力学特征;
2. 探索SIPI6398片在精神分裂症患者中多次给药的疗效。
[Translation] main purpose:
1. Evaluate the safety of multiple administrations of SIPI6398 tablets in patients with schizophrenia.
Secondary purpose:
1. Evaluate the pharmacokinetic characteristics of SIPI6398 tablets after multiple administration in patients with schizophrenia;
2. Explore the efficacy of multiple administrations of SIPI6398 tablets in patients with schizophrenia.